Introduction/Aim. Roughly six percent of all malignancies diagnosed in children are malignant bone tumors. They have a dramatic effect on psychological status of children and their families. The aim of the study was to analyze the clinico-pathological features of bone tumors in Iraqi children and to assess response to treatment, outcome, and survival. Patients and methods. Over an eleven-year period, a retrospective study was done for children with bone tumors conducted on patients data that included a battery of pre-treatment investigations including a complete blood count, serum electrolyte, hepatic, and renal profile, bone marrow aspirate and biopsy, fine-needle aspiration, and imaging studies. Results. Data of 41 children with bone tumor were collected. The most common site of involvement was lower limbs, found in 21 (51.2%) cases. At the time of diagnosis, 29 patients presented with localized disease (70.7%), while 12 (29.3%) patients presented with metastasis. From 41 patients included in the study, histopathology of 29 (70.7%) patients was Ewing's sarcoma, whereas 12 (29.3%) patients were diagnosed with osteogenic sarcoma. The most common toxic effect of chemotherapy was febrile neutropenia which was recorded in 22 (59.5%) patients, followed by hemorrhagic cystitis in 3 (8.1%) patients; both febrile neutropenia and hemorrhagic cystitis were recorded in 5 (13.5%) patients, convulsion was found in 1 (2.7%) patient, and no complication were reported in 5 (13.5%) patients. Relapse was found in 8 (21.6%) patients. Conclusion. High rate of patients were lost to follow-up. Two-year event-free survival (EFS) was 53%, which is lower than that reported in other studies due to late diagnosis, late referral with the presentation in the locally advanced stage of disease.
References
1.
Lanzkowsky P. Manual of pediatric hematology and oncology. 2005.
2.
Mohammed SE, Youssef BA, Ghonai DA, Ahmed EF, Mohammed EG, Abdo MA, et al. A Role of Therapy that Targets Immune Checkpoint Proteins for the Treatment of Melanoma Brain Metastasis, Liver, Breast, Pancreatic Cancer and Pancreatic Adenocarcinoma. AL-Kindy College Medical Journal. 18(3):173–80.
3.
Flamerz BM. Secondary skull tumors: Prevalence, MRI findings as a diagnostic tool, and treatment. AL-Kindy Col Med J. 2016;12(1):68–73.
4.
Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. Cancer incidence and survival among children and adolescents: United States SEER Program. 1975;1995(1999):99–110.
5.
Obalum DC, Giwa SO, Banjo AF, Akinsulire AT. Primary bone tumours in a tertiary hospital in Nigeria: 25 year review. Niger J Clin Pract. 2009;12(2):169–72.
6.
Omololu A, Ogunbiyi J, Ogunlade S, Alonge T, Adebisi A, Akang E. Primary malignant bone tumour in a tropical African University Teaching Hospital. West African Journal of Medicine. 21(4).
7.
Guerra RB, Tostes MD, da Costa Miranda L, de Camargo OP, Baptista AM, Caiero MT, et al. COMPARATIVE ANALYSIS BETWEEN OSTEOSARCOMA AND EWING’S SARCOMA: EVALUATION OF THE TIME FROM ONSET OF SIGNS AND SYMPTOMS UNTIL DIAGNOSIS. Clinics. 2006;61(2):99–106.
8.
Sluga M, Windhager R, Pfeiffer M, Ofner P, Lang S, Dominkus M, et al. Osteosarkom und Ewing-Sarkom - die häufigsten Knochentumoren bei Kindern: Therapie und Ergebnisse. Zeitschrift für Orthopädie und ihre Grenzgebiete. 140(06):652–5.
9.
Haidar R, Sagghieh S, Muwakitt S, Mumtaz G, Akel S, Kamzoul R, et al. Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatric Blood & Cancer. 2008;51(6):787–91.
10.
Körholz D, Verheyen J, Engelbrecht V, Guillaume T, Vosberg H, Göbel U. Nachsorge bei Patienten mit Osteosarkom und Ewing-Tumoren - Eine retrospektive Nutzenanalyse -. Klinische Pädiatrie. 2000;212(4):220–3.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
